Cas:387834-41-5 [(1R,5R)-3-(bromomethylidene)-5-[tert-butyl(dimethyl)silyl]oxycyclohexyl]oxy-tert-butyl-dimethylsilane manufacturer & supplier

We serve Chemical Name:[(1R,5R)-3-(bromomethylidene)-5-[tert-butyl(dimethyl)silyl]oxycyclohexyl]oxy-tert-butyl-dimethylsilane CAS:387834-41-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

[(1R,5R)-3-(bromomethylidene)-5-[tert-butyl(dimethyl)silyl]oxycyclohexyl]oxy-tert-butyl-dimethylsilane

Chemical Name:[(1R,5R)-3-(bromomethylidene)-5-[tert-butyl(dimethyl)silyl]oxycyclohexyl]oxy-tert-butyl-dimethylsilane
CAS.NO:387834-41-5
Synonyms:b2779;(1r,3r)-5-(bromomethylene)-1,3-bis(tert-butyldimethylsilyloxy)cyclohexane
Molecular Formula:C19H39BrO2Si2
Molecular Weight:435.58700
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:387.474ºC at 760 mmHg
Density:1.052g/cm3
Index of Refraction:1.474
PSA:18.46000
Exact Mass:434.16700
LogP:7.22990

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like b2779 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(1r,3r)-5-(bromomethylene)-1,3-bis(tert-butyldimethylsilyloxy)cyclohexane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(1r,3r)-5-(bromomethylene)-1,3-bis(tert-butyldimethylsilyloxy)cyclohexane Use and application,b2779 technical grade,usp/ep/jp grade.


Related News: He also mentioned that derivatives of these APIs and lot of other value-added APIs in the same range will also be manufactured at the new facility. 4-(3-Hydroxy-3-naphthalen-1-yl-propyl)-benzonitrile manufacturers AstraZeneca’s deal, the largest struck last year, is all part of CEO Pascal Soriot’s mission to hit $40 billion in global sales by 2023. 1H-Phenalene-1,3(2H)-dione, 6-bromo-2-(2,4-dimethylphenyl)- suppliers The company will see an immediate $6 billion bump to its topline thanks to Alexion’s C5 inhibitors, used to treat rare diseases like paroxysmal nocturnal hemoglobinuria. [Ga(III)(corrolato)] vendor & factory.